Afresh is an AI-powered platform designed to optimize the fresh food supply chain for grocery retailers. By leveraging advanced machine learning, Afresh enhances demand forecasting and inventory management, enabling grocers to reduce food waste, improve order accuracy, and increase sales. The platform has demonstrated significant traction, with metrics showing a 3% sales increase, 94% adherence rate, and a 25% reduction in shrink. Afresh's commitment to sustainability is evident as it has prevented over 30.6 million pounds of food waste, contributing to a more efficient and environmentally friendly grocery industry.
AlphaSense is a market intelligence platform that allows professionals to make critical decisions with confidence and speed. The company has nearly 2,000 enterprise clients, including financial institutions that use the platform to inform their business decisions. AlphaSense is trusted by over 1,800 enterprise customers, including a majority of the S&P 500.
Anyword is an AI-driven content generation platform that empowers marketers to create high-performing, on-brand content across various channels. It leverages performance predictions and data-driven insights to optimize messaging for business goals, ensuring that content resonates with target audiences. With features like a data-driven editor, brand voice centralization, and integration capabilities with popular tools, Anyword helps marketing teams streamline workflows and enhance engagement. The platform has demonstrated significant traction, with users reporting a 30% increase in sales and business performance compared to baseline AI models, positioning Anyword as a leader in the generative AI space for marketing.
Aro Homes aims to redefine residential construction by building better, more sustainable homes faster, and more efficiently. The company designs and builds carbon-negative, precision-engineered, user-experience-optimized homes that are faster and less expensive than traditional homes. It owns the process from start to finish, employing machine learning to identify optimal properties. Aro's designs were also influenced by machine learning, as its algorithms ingested large amounts of property data to assess local zoning requirements as well as sustainability and livability goals.
Atom Computing builds truly scalable quantum computers out of individual atoms. The company's quantum computers use quantum mechanical properties of atoms to process information and solve problems beyond the reach of traditional computers, including drug design, computational chemistry, and more. Atom Computing was founded in 2018 and based in Berkeley, California.
Augment Code is a developer AI platform designed for teams, integrating specific organizational knowledge and practices into every interaction. It enhances software development by providing instant responses, codebase-wide suggestions, and real-time completions, allowing developers to work smarter and faster. With a focus on privacy and security, Augment is built to scale from startups to Fortune 500 companies, making it a valuable tool for improving productivity and collaboration in software engineering.
Averna is a leading provider of automated test and quality assurance solutions for various industries, including aerospace, automotive, and consumer electronics. The company specializes in smart manufacturing, prototyping, and consulting services, offering a range of products such as RF signal testers and smart data management tools. Averna differentiates itself through its unique test integration expertise and commitment to zero defects, helping clients accelerate product development and improve quality. With a global presence and a strong focus on innovation, Averna is well-positioned in the market, serving a diverse clientele and driving digital transformation in manufacturing.
Big Hat Biosciences is a Series B biotech company based outside San Francisco that leverages machine learning and synthetic biology to design safer and more effective antibody therapies. Their Milliner platform integrates a high-speed wet lab with advanced machine learning technologies, enabling the rapid synthesis, purification, and characterization of hundreds of recombinant antibodies weekly. With a pipeline of wholly-owned and partnered therapeutic programs, Big Hat has raised over $100 million from top investors and is recognized for its innovative approach to tackling complex diseases through next-generation antibody therapies.
